Episurf Medical enters into distribution agreement for Spain and Portugal
Episurf Medical (Nasdaq: EPIS B) today announces that the company has appointed Medcom Tech as distributor for Episurf Medical’s implant technology, comprising Episealer® Knee and Episealer® Talus, in Spain and Portugal. Medcom Tech is a development and distribution company focusing on orthopaedic surgery, traumatology, neurosurgery and anesthesia. The company has approximately 140 employees and is headquartered in Spain.
“Medcom Tech, which is a well-established company in Spain and Portugal. We look forward to offering our implant technology through the skilled sales force of Medcom Tech”, says Pål Ryfors, CEO Episurf Medical.
“Medcom Tech is very pleased with this agreement, Episurf perfectly matches with our strategy of bringing high technological companies to Spain and Portugal and help them to grow in our markets. Medcom Tech sells high innovative products in more than 500 hospitals in Spain and Portugal, says Juan Sagales, CEO Medcom Tech.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
[HtmlContact:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><strong><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">For more information, please contact:</span></strong></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt;">Pål Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">Tel:</span><span style="font-size: 10pt;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt;">Email: </span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
[HtmlTitle:protected] => <h1 style="line-height:120%;"><span style="font-family:arial,helvetica,sans-serif"><strong>Episurf Medical enters into distribution agreement for Spain and Portugal </strong></span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical (Nasdaq: EPIS B) today announces that the company has appointed Medcom Tech as distributor for Episurf Medical’s implant technology, comprising Episealer® Knee and Episealer® Talus, in Spain and Portugal. Medcom Tech is a development and distribution company focusing on orthopaedic surgery, traumatology, neurosurgery and anesthesia. The company has approximately 140 employees and is headquartered in Spain.
“Medcom Tech, which is a well-established company in Spain and Portugal. We look forward to offering our implant technology through the skilled sales force of Medcom Tech”, says Pål Ryfors, CEO Episurf Medical.
“Medcom Tech is very pleased with this agreement, Episurf perfectly matches with our strategy of bringing high technological companies to Spain and Portugal and help them to grow in our markets. Medcom Tech sells high innovative products in more than 500 hospitals in Spain and Portugal, says Juan Sagales, CEO Medcom Tech.
[HtmlBody:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="color:#0e101a">Episurf Medical (Nasdaq: EPIS B) today announces that the company has appointed Medcom Tech as distributor for Episurf Medical’s implant technology, comprising Episealer® Knee and Episealer® Talus, in Spain and Portugal. Medcom Tech is a development and distribution company focusing on orthopaedic surgery, traumatology, neurosurgery and anesthesia. The company has approximately 140 employees and is headquartered in Spain. </span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><em><span style="color:#0e101a">“Medcom Tech, which is a well-established company in Spain and Portugal. We look forward to offering our implant technology through the skilled sales force of Medcom Tech”</span></em><span style="color:#0e101a">, says Pål Ryfors, CEO Episurf Medical. </span></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="color:#0e101a">“<em>Medcom Tech is very pleased with this agreement, Episurf perfectly matches with our strategy of bringing high technological companies to Spain and Portugal and help them to grow in our markets. Medcom Tech sells high innovative products in more than 500 hospitals in Spain and Portugal</em>, says Juan Sagales, CEO Medcom Tech. </span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 12311
)
[2] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 9307
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
[Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3372082/1435386.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Episurf Medical enters into distribution agreement for Spain and Portugal
[Description:protected] => Episurf Medical enters into distribution agreement for Spain and Portugal
[CreateDate:protected] => 2021-06-22T12:30:03.807Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 4006164
[EncryptedId:protected] => 5F1A0FEE8893E393
[IsRegulatory:protected] =>
[PublishDate:protected] => 2021-06-22T12:30:00Z
[LastChangeDate:protected] => 2021-06-22T12:30:03.793Z
[Title:protected] => Episurf Medical enters into distribution agreement for Spain and Portugal
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/episurf-medical-enters-into-distribution-agreement-for-spain-and-portugal,c3372082
[LanguageVersions:protected] => Array
(
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)